HKD 0.34
(-6.94%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 344.07 Million CNY | -13.91% |
2022 | 399.65 Million CNY | 10.8% |
2021 | 360.69 Million CNY | 16.85% |
2020 | 308.69 Million CNY | 41.11% |
2019 | 218.76 Million CNY | 26.08% |
2018 | 173.51 Million CNY | 62.97% |
2017 | 106.46 Million CNY | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2023 Q2 | 203.67 Million HKD | 0.0% |
2023 FY | 344.07 Million CNY | -13.91% |
2023 Q4 | 177.15 Million HKD | 0.0% |
2022 FY | 399.65 Million CNY | 10.8% |
2022 Q4 | 228.44 Million HKD | 0.0% |
2022 Q2 | 236.75 Million HKD | 0.0% |
2021 Q2 | 206.14 Million HKD | 0.0% |
2021 FY | 360.69 Million CNY | 16.85% |
2021 Q4 | 228.62 Million HKD | 0.0% |
2020 Q4 | 89.85 Million CNY | 47.6% |
2020 Q3 | 60.87 Million CNY | 0.0% |
2020 FY | 308.69 Million CNY | 41.11% |
2019 Q4 | 45.79 Million CNY | 0.0% |
2019 FY | 218.76 Million CNY | 26.08% |
2018 FY | 173.51 Million CNY | 62.97% |
2017 FY | 106.46 Million CNY | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
CSPC Pharmaceutical Group Limited | 34.59 Billion HKD | 99.006% |